AbClon
AbClon is a South Korean biotech company founded in 2010 that develops advanced cell and gene therapy platforms and antibody drug technologies.
Last updated September 16, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
AbClon (앱클론(주)) is a biotechnology company based in Seoul, South Korea. According to its official website, it was founded in 2010 by a group of Korean and Swedish scientists and holds technology for developing advanced cell and gene therapy platforms to treat various cancers, positioning itself as a frontrunner in antibody drug development.
History
AbClon was founded in 2010 by a group of Korean and Swedish scientists. The company is based in Seoul, South Korea, and develops advanced cell and gene therapy platforms for treating various cancers, with a stated position as a frontrunner in antibody drug development.
Products and positioning
Frontrunner in antibody drug development with advanced cell and gene therapy platforms for cancer treatment
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/abclon-korea · Editorial policy · How profiles are compiled